GMP BPC-157 - 10mg - Research Use Only
What "GMP-Grade" Means for BPC-157
GMP stands for Good Manufacturing Practice, a defined production standard governing facility controls, documentation, and quality systems, not just a label. This BPC-157 10mg is manufactured in a true GMP facility, a stricter production standard than PekCura Labs' standard research-grade peptide line. For researchers comparing the best BPC-157 currently available, manufacturing standard is often the first meaningful differentiator, since it shapes batch-to-batch consistency before purity testing even begins.
Purity and Testing Rigor
This GMP BPC-157 10mg is manufactured to a purity of 99 percent or higher, and every batch is independently verified by Vanguard Laboratory, an ISO 17025:2017-accredited third-party testing facility. Testing includes HPLC analysis for purity and ICP-MS screening for heavy metals, and each vial links to its batch-specific Certificate of Analysis through an on-vial QR code. That level of testing rigor is what allows PekCura Labs to offer this as the highest-quality BPC-157 in its catalog, rather than relying on a purity claim alone.
Why Researchers Choose Premium-Grade BPC-157
When reproducibility matters, the manufacturing standard behind a peptide can matter as much as the sequence itself. Researchers evaluating the best place to get BPC-157 for demanding or long-running studies often choose the GMP-grade option specifically because it adds documented facility controls on top of the same third-party purity verification used across PekCura Labs products, making it the premium choice for labs that want that added manufacturing assurance built into every batch.
- CAS Number: 137525-51-0
- Molecular Formula: C62H98N15O22
- Molecular Weight: 1419.556 g/mol
- ≥99% Purity
- Stored at -20° in medical-grade freezers
- Research Grade Laboratory research use only
References
Józwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P. (2025). Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals, 18(2), 185. https://doi.org/10.3390/ph18020185
Seiwerth, S., Milavic, M., Vukojevic, J., et al. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology, 12, 627533.
https://doi.org/10.3389/fphar.2021.627533
Seiwerth, S., Sikiric, P., Grabarevic, Z., et al. (1997). BPC 157’s Effect on Healing. Journal of Physiology (Paris), 91(3), 173–178. https://pubmed.ncbi.nlm.nih.gov/9403790/
Vukojević, J., Milavić, M., Perović, D., et al. (2021). Pentadecapeptide BPC 157 and the Central Nervous System. Neural Regeneration Research, 17(3), 482–487. https://doi.org/10.4103/1673-5374.320969














